Results
|
81.
|
L-735,524: the design of a potent and orally bioavailable HIV protease inhibitor. [electronic resource] by
- Dorsey, B D
- Levin, R B
- McDaniel, S L
- Vacca, J P
- Guare, J P
- Darke, P L
- Zugay, J A
- Emini, E A
- Schleif, W A
- Quintero, J C
Producer: 19941123
In:
Journal of medicinal chemistry vol. 37
Availability: No items available.
|
|
82.
|
HIV-1 protease inhibitors: synthesis and biological evaluation of glycopeptidemimetics. [electronic resource] by
- Ghosh, A K
- McKee, S P
- Sanders, W M
- Darke, P L
- Zugay, J A
- Emini, E A
- Schleif, W A
- Quintero, J C
- Huff, J R
- Anderson, P S
Producer: 19931104
In:
Drug design and discovery vol. 10
Availability: No items available.
|
|
83.
|
Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy. [electronic resource] by
- Gulick, R M
- Mellors, J W
- Havlir, D
- Eron, J J
- Gonzalez, C
- McMahon, D
- Richman, D D
- Valentine, F T
- Jonas, L
- Meibohm, A
- Emini, E A
- Chodakewitz, J A
Producer: 19970911
In:
The New England journal of medicine vol. 337
Availability: No items available.
|
|
84.
|
Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine in adults 18-49 years of age, naive to 23-valent pneumococcal polysaccharide vaccine. [electronic resource] by
- Bryant, K A
- Frenck, R
- Gurtman, A
- Rubino, J
- Treanor, J
- Thompson, A
- Jones, T R
- Sundaraiyer, V
- Baxter, L M
- Gruber, W C
- Emini, E A
- Scott, D A
- Schmoele-Thoma, B
Producer: 20160727
In:
Vaccine vol. 33
Availability: No items available.
|
|
85.
|
Primary structure, gene organization and polypeptide expression of poliovirus RNA. [electronic resource] by
- Kitamura, N
- Semler, B L
- Rothberg, P G
- Larsen, G R
- Adler, C J
- Dorner, A J
- Emini, E A
- Hanecak, R
- Lee, J J
- van der Werf, S
- Anderson, C W
- Wimmer, E
Producer: 19810820
In:
Nature vol. 291
Availability: No items available.
|
|
86.
|
The consequence of passive administration of an anti-human immunodeficiency virus type 1 neutralizing monoclonal antibody before challenge of chimpanzees with a primary virus isolate. [electronic resource] by
- Conley, A J
- Kessler, J A
- Boots, L J
- McKenna, P M
- Schleif, W A
- Emini, E A
- Mark, G E
- Katinger, H
- Cobb, E K
- Lunceford, S M
- Rouse, S R
- Murthy, K K
Producer: 19961122
In:
Journal of virology vol. 70
Availability: No items available.
|
|
87.
|
3-year suppression of HIV viremia with indinavir, zidovudine, and lamivudine. [electronic resource] by
- Gulick, R M
- Mellors, J W
- Havlir, D
- Eron, J J
- Meibohm, A
- Condra, J H
- Valentine, F T
- McMahon, D
- Gonzalez, C
- Jonas, L
- Emini, E A
- Chodakewitz, J A
- Isaacs, R
- Richman, D D
Producer: 20000629
In:
Annals of internal medicine vol. 133
Availability: No items available.
|
|
88.
|
Simultaneous vs sequential initiation of therapy with indinavir, zidovudine, and lamivudine for HIV-1 infection: 100-week follow-up. [electronic resource] by
- Gulick, R M
- Mellors, J W
- Havlir, D
- Eron, J J
- Gonzalez, C
- McMahon, D
- Jonas, L
- Meibohm, A
- Holder, D
- Schleif, W A
- Condra, J H
- Emini, E A
- Isaacs, R
- Chodakewitz, J A
- Richman, D D
Producer: 19980716
In:
JAMA vol. 280
Availability: No items available.
|
|
89.
|
Antagonists of the human CCR5 receptor as anti-HIV-1 agents. Part 4: synthesis and structure-activity relationships for 1-[N-(methyl)-N-(phenylsulfonyl)amino]-2-(phenyl)-4-(4-(N-(alkyl)-N-(benzyloxycarbonyl)amino)piperidin-1-yl)butanes. [electronic resource] by
- Finke, P E
- Oates, B
- Mills, S G
- MacCoss, M
- Malkowitz, L
- Springer, M S
- Gould, S L
- DeMartino, J A
- Carella, A
- Carver, G
- Holmes, K
- Danzeisen, R
- Hazuda, D
- Kessler, J
- Lineberger, J
- Miller, M
- Schleif, W A
- Emini, E A
Producer: 20020312
In:
Bioorganic & medicinal chemistry letters vol. 11
Availability: No items available.
|
|
90.
|
Comparison of pneumococcal conjugate polysaccharide and free polysaccharide vaccines in elderly adults: conjugate vaccine elicits improved antibacterial immune responses and immunological memory. [electronic resource] by
- de Roux, Andrés
- Schmöle-Thoma, B
- Schmöele-Thoma, B
- Siber, G R
- Hackell, J G
- Kuhnke, A
- Ahlers, N
- Baker, S A
- Razmpour, A
- Emini, E A
- Fernsten, P D
- Gruber, W C
- Lockhart, S
- Burkhardt, O
- Welte, T
- Lode, H M
Producer: 20080617
In:
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America vol. 46
Availability: No items available.
|
|
91.
|
Combinatorial synthesis of CCR5 antagonists. [electronic resource] by
- Willoughby, C A
- Berk, S C
- Rosauer, K G
- Degrado, S
- Chapman, K T
- Gould, S L
- Springer, M S
- Malkowitz, L
- Schleif, W A
- Hazuda, D
- Miller, M
- Kessler, J
- Danzeisen, R
- Holmes, K
- Lineberger, J
- Carella, A
- Carver, G
- Emini, E A
Producer: 20020226
In:
Bioorganic & medicinal chemistry letters vol. 11
Availability: No items available.
|
|
92.
|
Residual human immunodeficiency virus (HIV) Type 1 RNA and DNA in lymph nodes and HIV RNA in genital secretions and in cerebrospinal fluid after suppression of viremia for 2 years. [electronic resource] by
- Günthard, H F
- Havlir, D V
- Fiscus, S
- Zhang, Z Q
- Eron, J
- Mellors, J
- Gulick, R
- Frost, S D
- Brown, A J
- Schleif, W
- Valentine, F
- Jonas, L
- Meibohm, A
- Ignacio, C C
- Isaacs, R
- Gamagami, R
- Emini, E
- Haase, A
- Richman, D D
- Wong, J K
Producer: 20010531
In:
The Journal of infectious diseases vol. 183
Availability: No items available.
|
|
93.
|
1,3,4-Trisubstituted pyrrolidine CCR5 receptor antagonists. Part 2: lead optimization affording selective, orally bioavailable compounds with potent anti-HIV activity. [electronic resource] by
- Hale, J J
- Budhu, R J
- Holson, E B
- Finke, P E
- Oates, B
- Mills, S G
- MacCoss, M
- Gould, S L
- DeMartino, J A
- Springer, M S
- Siciliano, S
- Malkowitz, L
- Schleif, W A
- Hazuda, D
- Miller, M
- Kessler, J
- Danzeisen, R
- Holmes, K
- Lineberger, J
- Carella, A
- Carver, G
- Emini, E
Producer: 20011210
In:
Bioorganic & medicinal chemistry letters vol. 11
Availability: No items available.
|
|
94.
|
Discovery of human CCR5 antagonists containing hydantoins for the treatment of HIV-1 infection. [electronic resource] by
- Kim, D
- Wang, L
- Caldwell, C G
- Chen, P
- Finke, P E
- Oates, B
- MacCoss, M
- Mills, S G
- Malkowitz, L
- Gould, S L
- DeMartino, J A
- Springer, M S
- Hazuda, D
- Miller, M
- Kessler, J
- Danzeisen, R
- Carver, G
- Carella, A
- Holmes, K
- Lineberger, J
- Schleif, W A
- Emini, E A
Producer: 20020226
In:
Bioorganic & medicinal chemistry letters vol. 11
Availability: No items available.
|
|
95.
|
Design, synthesis, and SAR of heterocycle-containing antagonists of the human CCR5 receptor for the treatment of HIV-1 infection. [electronic resource] by
- Kim, D
- Wang, L
- Caldwell, C G
- Chen, P
- Finke, P E
- Oates, B
- MacCoss, M
- Mills, S G
- Malkowitz, L
- Gould, S L
- DeMartino, J A
- Springer, M S
- Hazuda, D
- Miller, M
- Kessler, J
- Danzeisen, R
- Carver, G
- Carella, A
- Holmes, K
- Lineberger, J
- Schleif, W A
- Emini, E A
Producer: 20020226
In:
Bioorganic & medicinal chemistry letters vol. 11
Availability: No items available.
|
|
96.
|
Antagonists of the human CCR5 receptor as anti-HIV-1 agents. Part 2: structure-activity relationships for substituted 2-Aryl-1-[N-(methyl)-N-(phenylsulfonyl)amino]-4-(piperidin-1-yl)butanes. [electronic resource] by
- Finke, P E
- Meurer, L C
- Oates, B
- Mills, S G
- MacCoss, M
- Malkowitz, L
- Springer, M S
- Daugherty, B L
- Gould, S L
- DeMartino, J A
- Siciliano, S J
- Carella, A
- Carver, G
- Holmes, K
- Danzeisen, R
- Hazuda, D
- Kessler, J
- Lineberger, J
- Miller, M
- Schleif, W A
- Emini, E A
Producer: 20010510
In:
Bioorganic & medicinal chemistry letters vol. 11
Availability: No items available.
|
|
97.
|
Antagonists of the human CCR5 receptor as anti-HIV-1 agents. part 1: discovery and initial structure-activity relationships for 1 -amino-2-phenyl-4-(piperidin-1-yl)butanes. [electronic resource] by
- Dorn, C P
- Finke, P E
- Oates, B
- Budhu, R J
- Mills, S G
- MacCoss, M
- Malkowitz, L
- Springer, M S
- Daugherty, B L
- Gould, S L
- DeMartino, J A
- Siciliano, S J
- Carella, A
- Carver, G
- Holmes, K
- Danzeisen, R
- Hazuda, D
- Kessler, J
- Lineberger, J
- Miller, M
- Schleif, W A
- Emini, E A
Producer: 20010510
In:
Bioorganic & medicinal chemistry letters vol. 11
Availability: No items available.
|
|
98.
|
Identification of MK-944a: a second clinical candidate from the hydroxylaminepentanamide isostere series of HIV protease inhibitors. [electronic resource] by
- Dorsey, B D
- McDonough, C
- McDaniel, S L
- Levin, R B
- Newton, C L
- Hoffman, J M
- Darke, P L
- Zugay-Murphy, J A
- Emini, E A
- Schleif, W A
- Olsen, D B
- Stahlhut, M W
- Rutkowski, C A
- Kuo, L C
- Lin, J H
- Chen, I W
- Michelson, S R
- Holloway, M K
- Huff, J R
- Vacca, J P
Producer: 20001005
In:
Journal of medicinal chemistry vol. 43
Availability: No items available.
|
|
99.
|
Genetic correlates of in vivo viral resistance to indinavir, a human immunodeficiency virus type 1 protease inhibitor. [electronic resource] by
- Condra, J H
- Holder, D J
- Schleif, W A
- Blahy, O M
- Danovich, R M
- Gabryelski, L J
- Graham, D J
- Laird, D
- Quintero, J C
- Rhodes, A
- Robbins, H L
- Roth, E
- Shivaprakash, M
- Yang, T
- Chodakewitz, J A
- Deutsch, P J
- Leavitt, R Y
- Massari, F E
- Mellors, J W
- Squires, K E
- Steigbigel, R T
- Teppler, H
- Emini, E A
Producer: 19970123
In:
Journal of virology vol. 70
Availability: No items available.
|
|
100.
|
Control of viremia and prevention of clinical AIDS in rhesus monkeys by cytokine-augmented DNA vaccination. [electronic resource] by
- Barouch, D H
- Santra, S
- Schmitz, J E
- Kuroda, M J
- Fu, T M
- Wagner, W
- Bilska, M
- Craiu, A
- Zheng, X X
- Krivulka, G R
- Beaudry, K
- Lifton, M A
- Nickerson, C E
- Trigona, W L
- Punt, K
- Freed, D C
- Guan, L
- Dubey, S
- Casimiro, D
- Simon, A
- Davies, M E
- Chastain, M
- Strom, T B
- Gelman, R S
- Montefiori, D C
- Lewis, M G
- Emini, E A
- Shiver, J W
- Letvin, N L
Producer: 20001107
In:
Science (New York, N.Y.) vol. 290
Availability: No items available.
|